EFTR - Effector Therapeutics announces $15M registered direct offering
2024-01-25 08:31:21 ET
More on eFFECTOR Therapeutics
- eFFECTOR updates Phase 1/2 data for breast cancer therapy
- eFFECTOR stock rises after FDA fast track status for breast cancer therapy
- Seeking Alpha’s Quant Rating on eFFECTOR Therapeutics
- Historical earnings data for eFFECTOR Therapeutics
- Financial information for eFFECTOR Therapeutics